Researchers conducted a small, interview-based study to understand how therapists view psychedelic-assisted therapy. They spoke with seven therapists in Switzerland, where this treatment can be part of long-term clinical care. The goal was to explore the role of standard psychotherapy techniques when psychedelic medicines are involved.
The therapists described two main ideas. First, they adapt familiar psychotherapy methods for use with psychedelics, helping patients have meaningful therapeutic experiences. Second, they see a synergistic relationship where the psychedelic medicine can amplify core parts of therapy, like building trust and creating a sense of profundity during sessions.
The therapists generally agreed that psychedelics act as catalysts for psychotherapeutic processes. The study did not report on patient safety, side effects, or how well the treatment works. Because this research is based only on interviews with a very small group of therapists in one country, the findings are preliminary. They offer a professional perspective on how this therapy might be practiced, but do not tell us about patient results or whether the approach is broadly effective.
